Future clinical studies should investigate the effect of COX-2 inhibitors in adjunction to prescribed AEDs in large-sample, randomized, controlled trials with a parallel assessment of plasma PGE2 levels to substantiate the potential adjunctive application of COX-2 inhibitors for epilepsy treatment. This evidence concerns the gene PTGS2 and epilepsy.